Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1989-09-12
1990-12-11
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 24, 514293, 514303, 546256, 546271, 546118, A61K 3170, A61K 3144, C07H 1700, C07D40100
Patent
active
049771442
ABSTRACT:
Disclosed are the compounds of the formula ##STR1## wherein R represents hydrogen, lower alkyl, aryl or aryl-lower alkyl; R.sub.1 represents hydrogen, lower alkyl, C.sub.3 -C.sub.7 -alkenyl, carbocyclic or heterocyclic aryl, carbocyclic or heterocyclic aryl-lower alkyl, C.sub.3 -C.sub.7 -cycloalkyl, or optionally lower alkyl substituted (C.sub.3 -C.sub.7 -cycloalkyl, bicycloheptyl, bicycloheptenyl, adamantyl, tetrahydropyranyl or tetrahydrothiopyranyl)-lower alkyl, or diaryl-lower alkyl; R.sub.2 represents hydrogen or lower alkyl; R.sub.3 represents hydroxymethyl or --CONHR.sub.4 in which R.sub.4 represents hydrogen, lower alkyl, aryl-lower alkyl, C.sub.3 -C.sub.7 -cycloalkyl, C.sub.3 -C.sub.7 -cycloalkyl-lower alkyl or hydroxy-lower alkyl; pharmaceutically acceptable ester derivatives thereof in which one or more of the hydroxy groups are esterified in form of a pharmaceutically acceptable ester; and pharmaceutically acceptable salts thereof; methods of preparation; pharmaceutical compositions; and their use as adenosine-2 agonists in mammals.
REFERENCES:
patent: 4122172 (1978-10-01), Langenscheid
patent: 4276293 (1981-06-01), Lesher et al.
patent: 4714764 (1987-12-01), Sato et al.
patent: 4780452 (1988-10-01), Krenitsky et al.
Nucleosides and Nucleotides, 4, 625-639 (1985).
J. Pharmaceutical Sciences 73, 366 (1984).
J. Med. Chem. 31, 1179-1183 (1988).
J. Med. Chem. 30, 1686-1688 (1987).
Ital. J. Biochem. 31, 396 (1982).
J. Heterocyclic Chem. 15, 839 (1978).
Chem. Abstracts 105, 38047v (1986).
J. Enzyme Inhibition I, 67-75 (1985).
Francis John E.
Fujimoto Roger A.
Hutchison Alan J.
Ciba-Geigy Corporation
Gruenfeld Norbert
Lee Mary C.
Whittenbaugh Robert C.
LandOfFree
Imidazo[4,5-b]pyridine derivatives as cardiovascular agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazo[4,5-b]pyridine derivatives as cardiovascular agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazo[4,5-b]pyridine derivatives as cardiovascular agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-390335